Comparing 15 Vitamin C Serums
with Ascorbic Acid

How the comparison works

Formulation Rating is the equal mean of Antioxidant, Pigment Signalling and Hydration. Scores are calibrated on the same criteria across these 15 products and may differ from earlier individual-profile snapshots. These editorial formulation-fit scores describe ingredient and vehicle design: 1 poor, 2 tentative, 3 coherent, 4 strong and 5 exceptional. This comparison also permits editorial half-steps between these anchors: 3.5 sits between coherent and strong, while 4.5 sits between strong and exceptional formulation potential. The scale is not clinically validated, and these scores are not measured treatment outcomes. Hydration compares water binding, conditioning, moisture-retention and barrier-related architecture on a common basis: 3.5 good lightweight support, 4 strong complementary support, 4.5 particularly persuasive support and 5 the most integrated design in this cohort. Tied hydration scores do not establish a clinical order; no head-to-head hydration measurements underpin these ratings. Pigment Signalling assesses comparative pigmentation support, including complementary renewal and transfer-related roles. Dr Dennis Gross is the 5-star relative benchmark for its integrated design and product-specific pigmentation reporting, not a proven clinical winner. Its brand study lacks a fully disclosed comparator/protocol; SkinCeuticals’ pigment evidence includes a small post-laser adjunct study, not equivalent standalone-use proof. Supporting ingredient doses remain relevant uncertainties. Peptide and collagen scores are not added separately. In this ascorbic-acid-focused comparison, Sturm receives coherent rather than strong antioxidant and pigment-fit scores because its central pure-acid exposure cannot be established from the disclosed 5% complex. This is a scope-specific editorial judgement, not a blanket penalty for undisclosed supporting ingredients or proof of poorer clinical results.

Value Rating combines 70% relative affordability by AUD price per 10 mL and 30% relative affordability by that price divided by the disclosed L-ascorbic acid percentage. Each component is min–max normalised, converted to a 1–5 scale, then rounded to the nearest half-star. All 15 prices define the price range; the 14 disclosed pure-ascorbic-acid doses define the concentration-adjusted range. Sturm is price-only because its 5% complex does not disclose the L-ascorbic acid share. Concentration adjustment is an economic proxy, not evidence of better efficacy, stability, delivery or tolerance.

Overall Rating is the mean of the displayed Formulation Rating and Value Rating, rounded half-up to two decimals. Both tables follow this ranking. Values have been recalculated for this 15-product group; they are not the scores from the earlier eight-product comparison. The ranking changes with the cohort and pricing.